Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors

被引:0
作者
Kayondo, Jonathan K. [1 ]
Ndembi, Nicaise [2 ]
Parry, Chris M. [2 ]
Cane, Patricia A. [3 ]
Hue, Stephane [4 ]
Goodall, Ruth [5 ]
Dunn, David T. [5 ]
Kaleebu, Pontiano [1 ,2 ]
Pillay, Deenan [4 ]
Mbisa, Jean L. [3 ]
机构
[1] Uganda Virus Res Inst, Uganda Res Unit AIDS, Entebbe, Uganda
[2] UVRI, MRC, Uganda Res Unit AIDS, Entebbe, Uganda
[3] Publ Hlth England, Virus Reference Dept, London, England
[4] UCL, Dept Infect & Immun, London, England
[5] UCL, MRC, Clin Trials Unit, London, England
基金
英国惠康基金;
关键词
DRUG-RESISTANCE; HIV; INTERRUPTION; INFECTION;
D O I
10.1089/aid.2015.0035
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Structured treatment interruption (STI) has been trialed as an alternative to lifelong antiretroviral therapy (ART). We retrospectively performed single genome sequencing of the HIV-1 pol region from three patients representing different scenarios. They were either failing on continuous therapy (CT-F), failing STI (STI-F), or suppressing on STI (STI-S). Over 460 genomes were generated from three to five different time points over a 2-year period. We found multiple-linked-resistant mutations in both treatment failures. However, the CT-F patient showed a stepwise accumulation of diverse, linked mutations whereas the STI-F patient had lineage turnover between treatment periods with recirculation of wild-type and resistant variants from reservoirs. The STI-F patient showed a 7-fold increase in the third codon position substitution rate relative to the first and second positions compared to a 2-fold increase for CT-F and increased purifying selection in the pol gene (62 vs. 22 sites, respectively). An understanding of intrapatient viral dynamics could guide the future direction of treatment interruption strategies.
引用
收藏
页码:749 / 756
页数:8
相关论文
共 50 条
  • [41] Identification of a Non-Nucleoside Reverse Transcriptase Inhibitor against Human Immunodeficiency Virus-1
    Kim, Min-Jung
    Yu, Kyung Lee
    Han, Ri
    Lee, Yoonji
    Oh, Kyungsoo
    You, Ji Chang
    ACS INFECTIOUS DISEASES, 2023, 9 (08): : 1582 - 1592
  • [42] Characterization of human immunodeficiency virus type-1 (HIV-1) particles that express protease-reverse transcriptase fusion proteins
    Cherry, E
    Liang, C
    Rong, LW
    Quan, YD
    Inouye, P
    Li, XG
    Morin, N
    Kotler, N
    Wainberg, MA
    JOURNAL OF MOLECULAR BIOLOGY, 1998, 284 (01) : 43 - 56
  • [43] Effect of antimetabolite drugs of nucleotide metabolism on the anti-human immunodeficiency virus activity of nucleoside reverse transcriptase inhibitors
    Balzarini, J
    PHARMACOLOGY & THERAPEUTICS, 2000, 87 (2-3) : 175 - 187
  • [44] Synthesis of nucleosidyl rifamycins as inhibitors of human immunodeficiency virus type 1
    Bartolucci, C
    Cellai, L
    Mannina, L
    Marzano, M
    Brufani, M
    Filocamo, L
    Messina, S
    Brizzi, V
    Benedetto, A
    DiCaro, A
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1997, 8 (03) : 215 - 221
  • [45] Evolutionary Analysis of Human Immunodeficiency Virus Type 1 Therapies Based on Conditionally Replicating Vectors
    Ke, Ruian
    Lloyd-Smith, James O.
    PLOS COMPUTATIONAL BIOLOGY, 2012, 8 (10)
  • [46] Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon
    Fokam, J.
    Salpini, R.
    Santoro, M. M.
    Cento, V.
    D'Arrigo, R.
    Gori, C.
    Perno, C. F.
    Colizzi, V.
    Nanfack, A.
    Gwom, L. C.
    Cappelli, G.
    Takou, D.
    ARCHIVES OF VIROLOGY, 2011, 156 (07) : 1235 - 1243
  • [47] NNRTI-selected mutations at codon 190 of human immunodeficiency virus type 1 reverse transcriptase decrease susceptibility to stavudine and zidovudine
    Paolucci, Stefania
    Baldanti, Fausto
    Campanini, Giulia
    Cancio, Reynel
    Belfiore, Amalia
    Maga, Giovanni
    Gerna, Giuseppe
    ANTIVIRAL RESEARCH, 2007, 76 (02) : 99 - 103
  • [48] Summary Report from the Human Immunodeficiency Virus and Aging Consensus Project: Treatment Strategies for Clinicians Managing Older Individuals with the Human Immunodeficiency Virus
    Abrass, Christine K.
    Appelbaum, Jonathan S.
    Boyd, Cynthia M.
    Braithwaite, R. Scott
    Broudy, Virginia C.
    Covinsky, Kenneth
    Crothers, Kristina Anne
    Harrington, Robert
    Drootin, Marianna
    Gebo, Kelly
    Goodkin, Karl
    Havlik, Richard J.
    Hazzard, William
    High, Kevin
    Hsue, Priscilla
    John, Malcolm D.
    Justice, Amy
    Karpiak, Stephen
    McCormick, Wayne C.
    McNicholl, Ian R.
    Newman, Anne
    Simone-Skidmore, Mark J.
    South, Ken
    Spach, David
    Valcour, Victor
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2012, 60 (05) : 974 - 979
  • [49] Structure-based design of non-nucleoside reverse transcriptase inhibitors of drug-resistant human immunodeficiency virus
    Mao, C
    Sudbeck, EA
    Venkatachalam, TK
    Uckun, FM
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1999, 10 (05) : 233 - 240
  • [50] Inhibition of wild-type human immunodeficiency virus and reverse transcriptase inhibitor-resistant variants by Phyllanthus amarus
    Notka, F
    Meier, GR
    Wagner, R
    ANTIVIRAL RESEARCH, 2003, 58 (02) : 175 - 186